Bgm (BGM) Invested Capital (2019 - 2025)
Bgm's (BGM) quarterly Invested Capital came in at $1.6 million in Q3 2025, down 81.2% year-on-year from $8.6 million in Q3 2024, and up 1.02% on a QoQ basis from $1.6 million in Q1 2025.
Bgm (BGM) Invested Capital (2019 - 2025) Analysis & Trends
Bgm (BGM) has 6 years of Invested Capital data on file, last reported at $1.6 million in Q3 2025.
- On a quarterly basis, Invested Capital fell 81.2% year-over-year to $1.6 million in Q3 2025; TTM through Sep 2025 was $11.8 million, a 30.16% increase from a year earlier, with the FY2025 full-year figure at $1.6 million, down 81.2% from the prior year.
- Invested Capital for Q3 2025 stood at $1.6 million, up from $1.6 million in the prior quarter.
- Over the last five years, Invested Capital for BGM reached as high as $3153.0 billion in Q1 2022 and fell as low as $140578.0 in Q3 2022.
- Historically, Invested Capital has averaged $525.5 billion across 4 years, with a median of $1.6 million in 2025.
- Across the five-year window, Invested Capital surged 1694.26% in 2024 and tumbled 81.2% in 2025, its largest moves.
- Year by year, Invested Capital stood at $140578.0 in 2022, then soared by 241.24% to $479715.0 in 2023, then jumped by 1694.26% to $8.6 million in 2024, then tumbled by 81.2% to $1.6 million in 2025.
- Per Business Quant data, the three most recent Invested Capital figures were $1.6 million in Q3 2025, $1.6 million in Q1 2025, and $8.6 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 31.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 7.15 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.93 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 73.00 Mn |
| 10 | Bgm | 45.84 Mn | 37.04 Mn | - | 1.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.62 Mn |
| Mar 31, 2025 | 1.60 Mn |
| Sep 30, 2024 | 8.61 Mn |
| Sep 30, 2023 | 479,715.00 |
| Sep 30, 2022 | 140,578.00 |
| Mar 31, 2022 | 3,153.03 Bn |
| Sep 30, 2020 | 7.35 Mn |
| Sep 30, 2019 | 4.90 Mn |